2014 Q4 Form 10-Q Financial Statement
#000119312514411349 Filed on November 13, 2014
Income Statement
Concept | 2014 Q4 | 2014 Q3 | 2013 Q3 |
---|---|---|---|
Revenue | $75.00K | $75.00K | $158.0K |
YoY Change | -75.73% | -52.53% | |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $4.790M | $5.300M | $2.142M |
YoY Change | 59.67% | 147.43% | |
% of Gross Profit | |||
Research & Development | $9.130M | $8.600M | $6.284M |
YoY Change | 46.31% | 36.86% | |
% of Gross Profit | |||
Depreciation & Amortization | $490.0K | $600.0K | $400.0K |
YoY Change | 0.0% | 50.0% | -55.06% |
% of Gross Profit | |||
Operating Expenses | $13.92M | $13.90M | $8.426M |
YoY Change | 50.65% | 64.97% | |
Operating Profit | -$13.83M | -$8.268M | |
YoY Change | 67.21% | ||
Interest Expense | -$200.0K | $228.0K | $351.0K |
YoY Change | 25.0% | -35.04% | |
% of Operating Profit | |||
Other Income/Expense, Net | -$160.0K | -$5.000K | -$38.00K |
YoY Change | -83.84% | -86.84% | |
Pretax Income | -$14.21M | -$13.98M | -$8.880M |
YoY Change | 40.97% | 57.43% | |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$14.21M | -$13.98M | -$8.879M |
YoY Change | 40.95% | 57.42% | |
Net Earnings / Revenue | -18949.33% | -18636.0% | -5619.62% |
Basic Earnings Per Share | -$0.60 | -$0.60 | -$55.90 |
Diluted Earnings Per Share | -$0.60 | -$0.60 | -$55.90 |
COMMON SHARES | |||
Basic Shares Outstanding | 23.72M shares | 23.33M shares | 228.8K shares |
Diluted Shares Outstanding | 23.33M shares | 228.8K shares |
Balance Sheet
Concept | 2014 Q4 | 2014 Q3 | 2013 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $171.0M | $187.5M | $1.900M |
YoY Change | 4284.62% | 9768.42% | |
Cash & Equivalents | $171.0M | $187.5M | $1.909M |
Short-Term Investments | |||
Other Short-Term Assets | $239.0K | $86.00K | $1.100M |
YoY Change | 246.38% | -92.18% | |
Inventory | |||
Prepaid Expenses | $1.085M | $1.451M | |
Receivables | $300.0K | $1.421M | |
Other Receivables | $0.00 | $0.00 | |
Total Short-Term Assets | $172.7M | $190.9M | $3.000M |
YoY Change | 3488.1% | 6263.67% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $19.27M | $17.39M | $13.10M |
YoY Change | 34.64% | 32.78% | |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $29.00K | $183.0K | $2.800M |
YoY Change | -99.04% | -93.46% | |
Total Long-Term Assets | $19.74M | $18.01M | $15.90M |
YoY Change | 10.69% | 13.28% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $172.7M | $190.9M | $3.000M |
Total Long-Term Assets | $19.74M | $18.01M | $15.90M |
Total Assets | $192.5M | $208.9M | $18.90M |
YoY Change | 749.94% | 1005.41% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.149M | $2.666M | $10.10M |
YoY Change | -43.01% | -73.6% | |
Accrued Expenses | $4.145M | $3.317M | $4.900M |
YoY Change | -0.38% | -32.31% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $2.900M | $8.800M | $8.300M |
YoY Change | -87.34% | 6.02% | |
Total Short-Term Liabilities | $10.24M | $14.75M | $31.70M |
YoY Change | -78.48% | -53.48% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $600.0K | $900.0K | $6.300M |
YoY Change | -84.62% | -85.71% | |
Other Long-Term Liabilities | $5.300M | $5.300M | $4.700M |
YoY Change | 10.42% | 12.77% | |
Total Long-Term Liabilities | $5.900M | $6.200M | $11.00M |
YoY Change | -32.18% | -43.64% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $10.24M | $14.75M | $31.70M |
Total Long-Term Liabilities | $5.900M | $6.200M | $11.00M |
Total Liabilities | $16.10M | $21.01M | $42.60M |
YoY Change | -71.36% | -50.69% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$258.8M | -$244.6M | |
YoY Change | 32.12% | ||
Common Stock | $435.2M | $432.5M | |
YoY Change | 1035.28% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $176.4M | $187.9M | -$23.70M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $192.5M | $208.9M | $18.90M |
YoY Change | 749.94% | 1005.41% |
Cashflow Statement
Concept | 2014 Q4 | 2014 Q3 | 2013 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$14.21M | -$13.98M | -$8.879M |
YoY Change | 40.95% | 57.42% | |
Depreciation, Depletion And Amortization | $490.0K | $600.0K | $400.0K |
YoY Change | 0.0% | 50.0% | -55.06% |
Cash From Operating Activities | -$9.120M | -$12.69M | -$6.470M |
YoY Change | -34.76% | 96.14% | -61.35% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$1.540M | -$2.020M | -$350.0K |
YoY Change | -59.58% | 477.14% | 66.67% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | |
YoY Change | |||
Cash From Investing Activities | -$1.610M | -$2.030M | -$360.0K |
YoY Change | -57.63% | 463.89% | 80.0% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -5.800M | -1.110M | -2.190M |
YoY Change | -129.31% | -49.32% | -161.86% |
NET CHANGE | |||
Cash From Operating Activities | -9.120M | -12.69M | -6.470M |
Cash From Investing Activities | -1.610M | -2.030M | -360.0K |
Cash From Financing Activities | -5.800M | -1.110M | -2.190M |
Net Change In Cash | -16.53M | -15.83M | -9.020M |
YoY Change | -922.39% | 75.5% | -32.69% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$9.120M | -$12.69M | -$6.470M |
Capital Expenditures | -$1.540M | -$2.020M | -$350.0K |
Free Cash Flow | -$7.580M | -$10.67M | -$6.120M |
YoY Change | -25.47% | 74.35% | -62.98% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2014Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
23719902 | shares |
CY2013Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1909000 | |
CY2013Q3 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
1748000 | |
CY2014Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
23717902 | shares |
CY2014Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
23717902 | shares |
CY2014Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
95000000 | shares |
CY2014Q3 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | shares |
CY2014Q3 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
5000000 | shares |
CY2014Q3 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
0 | shares |
CY2014Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q3 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.001 | |
CY2014Q3 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
924000 | |
CY2014Q3 | us-gaap |
Minimum Lease Payments Sale Leaseback Transactions Remainder Of Fiscal Year
MinimumLeasePaymentsSaleLeasebackTransactionsRemainderOfFiscalYear
|
105000 | |
CY2014Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
9749000 | |
CY2014Q3 | us-gaap |
Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
|
0 | |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
37932000 | |
CY2014Q3 | us-gaap |
Minimum Lease Payments Sale Leaseback Transactions Within Three Years
MinimumLeasePaymentsSaleLeasebackTransactionsWithinThreeYears
|
423000 | |
CY2014Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
14747000 | |
CY2014Q3 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
1647000 | |
CY2014Q3 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
0 | |
CY2014Q3 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
42000 | |
CY2014Q3 | us-gaap |
Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
|
0 | |
CY2014Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
24000 | |
CY2014Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2014Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2666000 | |
CY2014Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-244585000 | |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
5394000 | |
CY2014Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
432475000 | |
CY2014Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3317000 | |
CY2014Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
187914000 | |
CY2014Q3 | us-gaap |
Minimum Lease Payments Sale Leaseback Transactions Within Two Years
MinimumLeasePaymentsSaleLeasebackTransactionsWithinTwoYears
|
423000 | |
CY2014Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
187486000 | |
CY2014Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
17394000 | |
CY2014Q3 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
75000 | |
CY2014Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3349000 | |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
54846000 | |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
5222000 | |
CY2014Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
208922000 | |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
5070000 | |
CY2014Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
8662000 | |
CY2014Q3 | us-gaap |
Minimum Lease Payments Sale Leaseback Transactions
MinimumLeasePaymentsSaleLeasebackTransactions
|
1092000 | |
CY2014Q3 | us-gaap |
Liabilities
Liabilities
|
21008000 | |
CY2014Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1779000 | |
CY2014Q3 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
3676000 | |
CY2014Q3 | us-gaap |
Purchase Obligation
PurchaseObligation
|
14200000 | |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
1228000 | |
CY2014Q3 | us-gaap |
Minimum Lease Payments Sale Leaseback Transactions Within Four Years
MinimumLeasePaymentsSaleLeasebackTransactionsWithinFourYears
|
141000 | |
CY2014Q3 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
435000 | |
CY2014Q3 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
183000 | |
CY2014Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
67000 | |
CY2014Q3 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
4028000 | |
CY2014Q3 | us-gaap |
Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
|
241000 | |
CY2014Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
27143000 | |
CY2014Q3 | us-gaap |
Assets
Assets
|
208922000 | |
CY2014Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1421000 | |
CY2014Q3 | us-gaap |
Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
|
0 | |
CY2014Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
86000 | |
CY2014Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
183000 | |
CY2014Q3 | us-gaap |
Assets Current
AssetsCurrent
|
190910000 | |
CY2014Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
1451000 | |
CY2014Q3 | rvnc |
Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
|
404000 | |
CY2014Q3 | rvnc |
Financing Lease Obligation Noncurrent
FinancingLeaseObligationNoncurrent
|
938000 | |
CY2014Q3 | rvnc |
Working Capital Surplus
WorkingCapitalSurplus
|
176200000 | |
CY2014Q3 | rvnc |
Financing Lease Obligation Current
FinancingLeaseObligationCurrent
|
102000 | |
CY2014Q3 | rvnc |
Accrued Construction In Progress Expenditures Not Yet Paid Current
AccruedConstructionInProgressExpendituresNotYetPaidCurrent
|
168000 | |
CY2014Q3 | rvnc |
Reimbursable Tenant Improvements
ReimbursableTenantImprovements
|
150000 | |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4083000 | |
CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
260789 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
260789 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
224000000 | shares |
CY2013Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
8689999 | shares |
CY2013Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
145010269 | shares |
CY2013Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
478000 | |
CY2013Q4 | us-gaap |
Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
|
0 | |
CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2013Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
8689999 | shares |
CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.001 | |
CY2013Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
123982000 | |
CY2013Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
562000 | |
CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
8189000 | |
CY2013Q4 | us-gaap |
Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
|
215264000 | |
CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
47561000 | |
CY2013Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
1610000 | |
CY2013Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
2632000 | |
CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5526000 | |
CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-195880000 | |
CY2013Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
38331000 | |
CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4161000 | |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-157549000 | |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
22645000 | |
CY2013Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
4890000 | |
CY2013Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
83000 | |
CY2013Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
12157000 | |
CY2013Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
10702000 | |
CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
56212000 | |
CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
689000 | |
CY2013Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
3176000 | |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3914000 | |
CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
14315000 | |
CY2013Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
75000 | |
CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
825000 | |
CY2013Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
510000 | |
CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
22504000 | |
CY2013Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
194000 | |
CY2013Q4 | us-gaap |
Assets
Assets
|
22645000 | |
CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
225000 | |
CY2013Q4 | us-gaap |
Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
|
0 | |
CY2013Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
69000 | |
CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3006000 | |
CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4814000 | |
CY2013Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
531000 | |
CY2013Q4 | rvnc |
Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
|
169000 | |
CY2013Q4 | rvnc |
Common Stock Warrants Liability Current
CommonStockWarrantsLiabilityCurrent
|
3358000 | |
CY2013Q4 | rvnc |
Convertible Preferred Stock Warrant Liability Noncurrent
ConvertiblePreferredStockWarrantLiabilityNoncurrent
|
1233000 | |
CY2013Q4 | rvnc |
Deferred Initial Public Offering Costs
DeferredInitialPublicOfferingCosts
|
2812000 | |
CY2013Q4 | rvnc |
Accrued Construction In Progress Expenditures Not Yet Paid Current
AccruedConstructionInProgressExpendituresNotYetPaidCurrent
|
1757000 | |
CY2013Q4 | rvnc |
Accrued Offering Costs Current
AccruedOfferingCostsCurrent
|
506000 | |
CY2013Q4 | rvnc |
Derivative Liabilities Contract Current
DerivativeLiabilitiesContractCurrent
|
6684000 | |
CY2014Q1 | us-gaap |
Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
|
1 | pure |
CY2014Q1 | rvnc |
Conversion Of Convertible Preferred Stock Into Common Stock Shares
ConversionOfConvertiblePreferredStockIntoCommonStockShares
|
8689999 | shares |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
3.05 | ||
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
160873 | shares | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-33779000 | ||
us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
595284 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
971472 | shares | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
3.40 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
215315 | shares | |
us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
2966000 | ||
us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-75000 | ||
us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
858000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
304000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-201000 | ||
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
32008000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-29292000 | ||
us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
74894000 | ||
us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
2000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-40000 | ||
us-gaap |
Dilutive Securities
DilutiveSecurities
|
2233000 | ||
us-gaap |
Revenues
Revenues
|
308000 | ||
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
5594000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2672000 | ||
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
733000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-42369000 | ||
us-gaap |
Interest Paid
InterestPaid
|
1318000 | ||
us-gaap |
Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
|
-101000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
167000 | ||
us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
103000 | ||
us-gaap |
Interest Expense
InterestExpense
|
13466000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
29600000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
21592000 | ||
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
8008000 | ||
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
179000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-2174000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-3236000 | ||
us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
3300000 | ||
us-gaap |
Depreciation
Depreciation
|
1385000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
34202000 | ||
us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
21641000 | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
2862000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-2597000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
4000 | ||
us-gaap |
Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
|
4683000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
346000 | ||
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
5168000 | ||
rvnc |
Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock
DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock
|
177000 | ||
rvnc |
Non Cash Interest Income Expense
NonCashInterestIncomeExpense
|
-12148000 | ||
rvnc |
Conversion Of Convertible Preferred Stock Warrant
ConversionOfConvertiblePreferredStockWarrant
|
1168000 | ||
rvnc |
Interest Expense On Notes Payable
InterestExpenseOnNotesPayable
|
9178000 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.70 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Revance Therapeutics, Inc. | ||
dei |
Trading Symbol
TradingSymbol
|
RVNC | ||
us-gaap |
Operations Commenced Date1
OperationsCommencedDate1
|
2002-06-30 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
1999-08-10 | ||
dei |
Entity Information Date To Change Former Legal Or Registered Name
EntityInformationDateToChangeFormerLegalOrRegisteredName
|
2005-04-19 | ||
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.00 | pure | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-45951000 | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of Condensed Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and reported amounts of revenues and expenses during the reporting periods. Such management estimates include the fair value of common stock, stock-based compensation, fair value of convertible preferred stock and warrants, fair value of derivatives, and the valuation of deferred tax assets. The Company bases its estimates on historical experience and also on assumptions that it believes are reasonable, however, actual results could significantly differ from those estimates.</p> </div> | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-09-30 | ||
us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
If the Company experiences a greater than 50 percentage point aggregate change in ownership over a three-year period (a Section 382 ownership change), utilization of its pre-change net operating loss, or NOL, and credit carryforwards are subject to an annual limitation under Sections 382 and 383 of the Internal Revenue Code. California and New Jersey, where the Company files state tax returns, have similar laws. The annual limitation generally is determined by multiplying the value of the Company’s stock at the time of such ownership change (subject to certain adjustments) by the applicable long-term tax-exempt rate. | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
18009537 | shares | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.70 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001479290 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2025-01-31 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
18009537 | shares | |
us-gaap |
Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
|
1438000 | ||
us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-48705000 | ||
us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-75000 | ||
us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
146000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
1238000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2654000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-38203000 | ||
us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
18000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-73000 | ||
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
26206000 | ||
us-gaap |
Revenues
Revenues
|
308000 | ||
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
6230000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
5444000 | ||
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-48705000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-48705000 | ||
us-gaap |
Interest Paid
InterestPaid
|
971000 | ||
us-gaap |
Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
|
-500000 | ||
us-gaap |
Notes Assumed1
NotesAssumed1
|
1050000 | ||
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-8331000 | ||
us-gaap |
Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
|
800000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-83000 | ||
us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
649000 | ||
us-gaap |
Interest Expense
InterestExpense
|
10336000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
38511000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
24261000 | ||
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
14250000 | ||
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
148000 | ||
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
271000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
183572000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
1178000 | ||
us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
3900000 | ||
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
6750000 | ||
us-gaap |
Depreciation
Depreciation
|
1561000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
234892000 | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
1198000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-5369000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1402000 | ||
us-gaap |
Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
|
832000 | ||
us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
66000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4611000 | ||
us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
0 | ||
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-3524000 | ||
rvnc |
Non Cash Interest Income Expense
NonCashInterestIncomeExpense
|
-9365000 | ||
rvnc |
Issuance Of Common Stock Warrants
IssuanceOfCommonStockWarrants
|
981000 | ||
rvnc |
Conversion Of Seriese One Two Three Four Five Preferred Stock Into Common Stock
ConversionOfSerieseOneTwoThreeFourFivePreferredStockIntoCommonStock
|
123982000 | ||
rvnc |
Issuance Of Convertible Preferred Stock Warrants
IssuanceOfConvertiblePreferredStockWarrants
|
80000 | ||
rvnc |
Line Of Credit Facility Funding Term
LineOfCreditFacilityFundingTerm
|
P12M | ||
rvnc |
Issuance Of Common Stock Upon Net Exercise Of Warrants
IssuanceOfCommonStockUponNetExerciseOfWarrants
|
6490000 | ||
rvnc |
Adjustments To Additional Paid In Capital Termination Of Repurchase Rights Related To Common Stock Issued Pursuant To Early Exercises
AdjustmentsToAdditionalPaidInCapitalTerminationOfRepurchaseRightsRelatedToCommonStockIssuedPursuantToEarlyExercises
|
58000 | ||
rvnc |
Gain Loss On Warrant
GainLossOnWarrant
|
-1356000 | ||
rvnc |
Noncash Deferred Initial Public Offering Costs
NoncashDeferredInitialPublicOfferingCosts
|
546000 | ||
rvnc |
Gain Loss On Settlement In Exchange Of Preferred Stock Warrants
GainLossOnSettlementInExchangeOfPreferredStockWarrants
|
-1356000 | ||
rvnc |
Noncash Interest Expense
NoncashInterestExpense
|
9400000 | ||
rvnc |
Conversion Of Preferred Stock Warrants To Common Stock Warrants
ConversionOfPreferredStockWarrantsToCommonStockWarrants
|
1441000 | ||
rvnc |
Percentage Of Weighting To Determine Fair Value
PercentageOfWeightingToDetermineFairValue
|
1.00 | pure | |
CY2014Q1 | us-gaap |
Lessee Leasing Arrangements Operating Leases Renewal Term
LesseeLeasingArrangementsOperatingLeasesRenewalTerm
|
P36M | |
CY2013 | us-gaap |
Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
|
1800000 | |
CY2013Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-55.92 | |
CY2013Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
228785 | shares |
CY2013Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-55.92 | |
CY2013Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
228785 | shares |
CY2013Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-12793000 | |
CY2013Q3 | us-gaap |
Revenues
Revenues
|
158000 | |
CY2013Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-12793000 | |
CY2013Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6284000 | |
CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8883000 | |
CY2013Q3 | us-gaap |
Interest Paid
InterestPaid
|
392000 | |
CY2013Q3 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
103000 | |
CY2013Q3 | us-gaap |
Interest Expense
InterestExpense
|
351000 | |
CY2013Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
8426000 | |
CY2013Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8268000 | |
CY2013Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-38000 | |
CY2013Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2142000 | |
CY2013Q3 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1100000 | |
CY2013Q3 | us-gaap |
Depreciation
Depreciation
|
400000 | |
CY2013Q3 | rvnc |
Non Cash Interest Income Expense
NonCashInterestIncomeExpense
|
41000 | |
CY2014Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.60 | |
CY2014Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.00 | pure |
CY2014Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
23331104 | shares |
CY2014Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.60 | |
CY2014Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
23331104 | shares |
CY2014Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-13977000 | |
CY2014Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13825000 | |
CY2014Q3 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
14000 | |
CY2014Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-5000 | |
CY2014Q3 | us-gaap |
Revenues
Revenues
|
75000 | |
CY2014Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-13977000 | |
CY2014Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13977000 | |
CY2014Q3 | us-gaap |
Interest Paid
InterestPaid
|
276000 | |
CY2014Q3 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
238000 | |
CY2014Q3 | us-gaap |
Interest Expense
InterestExpense
|
228000 | |
CY2014Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
13900000 | |
CY2014Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8600000 | |
CY2014Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
5300000 | |
CY2014Q3 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1300000 | |
CY2014Q3 | us-gaap |
Depreciation
Depreciation
|
600000 | |
CY2014Q3 | rvnc |
Non Cash Interest Income Expense
NonCashInterestIncomeExpense
|
48000 |